Synonyms: Sermorelin;Sermorelin acetate;Yadaiftnsyrkvlgqlsarkllqdimsr-nh2
Sequence :H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-
Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-
Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
CAS: 86168-78-7
MF: C149H246N44O42S
MW: 3357.88
Purity (HPLC) 98.0%min.
Appearance White powder
Single Impurity (HPLC) 1.0%max
Amino Acid Composition ±10% of theoretical
Peptide Content (N%) ≥80.0%
Water Content (Karl Fischer) ≤8.0%
Acetate Content (HPIC) ≤12.0%
MS (ESI) Consistent
Specific Rotation (20/D) -80.0~-90.0°(c=0.5 1%HAc)
Mass Balance 95.0~105.0%
Usage: xanthine oxidase inhibitor
What is Sermorelin?
Sermorelin is a GHRH (growth hormone-releasing hormone) peptide analogue. Its peptide sequence is comprised of 29 amino acids. This sequence is a portion of the endogenous human GHRH, and is currently considered to be the shortest synthetic peptide that possesses the full array of functional GHRH activity. Due to this fact, sermorelin is considered to be a growth hormone secretagogue.
Sermorelin has been used during research to stimulate the secretion of growth hormone from the adenohypophysis (also called the anterior pituitary). The anterior pituitary secretes trophic hormones.
Product Name | Specification |
MGF | 2mg/vial |
PEG MGF | 2mg/vial |
CJC-1295 with DAC | 2mg/vial |
CJC-1295 without DAC | 2mg/vial |
PT-141 | 10mg/vial |
MT-1 | 10mg/vial |
MT-2 | 10mg/vial |
GHRP-2 | 5mg/vial |
GHRP-2 | 10mg/vial |
GHRP-6 | 5mg/vial |
GHRP-6 | 10mg/vial |
Ipamorelin | 2mg/vial |
Hexarelin | 2mg/vial |
Sermorelin | 2mg/vial |
Oxytocin | 2mg/vial |
TB500 | 2mg/vial |
Pentadecapeptide BPC 157 | 2mg/vial |
Fragment 176-191 | 2mg/vial |
Triptorelin | 2mg/vial |
Tesamorelin | 2mg/vial |
Gonadorelin | 2mg/vial |
Gonadorelin | 10mg/vial |
DSIP | 2mg/vial |
Selank | 5mg/vial |
Follistatin 344 | 1mg/vial |
Follistatin 315 | 1mg/vial |
Epitalon | 10mg/vial |
ACE 031 | 1mg/vial |
Adipotide | 2mg/vial |
AOD-9604 | 2mg/vial |
GDF-8 | 1mg/vial |
Deslorelin | 20mg/vial |